patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: Jupiter - look at the charts

Of course it can go back down to the .03's.  It's only at .043 now and this stock is very volatile.  Nothing against this company or it's tech but we've had several head fakes and plunges.  This stock is currently a swing traders dream.

Share
New Message
Please login to post a reply